Professional Documents
Culture Documents
Apmc Board Exam Im
Apmc Board Exam Im
INTERNAL MEDICINE
2005
Name________________________________________ Score__________
A. Write the best answer in the space provided before each number.
_____1. Among the viruses associated with causing bronchiectasis, choose the main
ones:
A. Coxsackie virus
B. Arena virus
C. Influenza Virus
D. Parvo virus
_____2. In patients with hospital acquired pneumonia, the following organisms are
commonly found in the ICU except:
A. Pseudomonas aeruginosa
B. Staphylococcus aureus
C. Acinetobacter spp.
D. Hemophilus influenzae
_____6. Pulmonary infections is common among patients with cystic fibrosis, therapy
should be directed against which of the following organisms:
A. Pseudomonas aeruginosa
B. Streptococcus pneumoniae
C. Chlamydia pneumoniae
D. None of the above
_____7. The following are radiologic signs which are found in patients with
pulmonary embolism:
A. Westermark’s sign
B. Hampton’s sign
C. Palla’s sign
D. All of the above
_____8. Aside from lung cancer, the other malignancy (cies) most commonly
associated with pleural effusion are:
A. Breast carcinoma
B. Hepatoma
C. Renal cell cancer
D. Colon cancer
_____10. What is the most common disease condition in patients waiting for a lung
transplant?
A. COPD
B. Idiopathic pulmonary fibrosis
C. Cystic fibrosis
D. Primary Pulmonary hypertension
_____12. In patients with atheroembolic stroke, the treatment most shown to have
benefits included:
A. Heparin
B. Aspirin
C. Dipyridamole
D. A and B
_____14. Asking a patient what they ate for breakfast this morning is testing his:
A. Working memory
B. Episodic memory
C. Long term memory
D. Procedural memory
_____17. Patients with acute renal failure secondary to gentamicin has the following
findings:
A. oliguric renal failure
B. elevated eosinophil count in the urine
C. presence of dirty brown coarse granular cast in the urine sediments
D. presence of red blood cell cast in the urine
_____21. Patients who are undergoing dialysis for the 1st time will experience this
condition due to rapid removal of toxic metabolites:
A. First use syndrome
B. Disequilibrium syndrome
C. Anaphylactic shock
D. Recirculation
_____22. Which of the following substances below are potent inhibitors of stone
formation?
A. Uric acid
B. Inorganic pyrophosphate
C. Oxalate
D. None of the above
_____23. A 5 year old male presenting with multiple cysts in the 2 kidneys associated
with hepatic fibrosis is most likely to have:
A. autosomal dominant polycystic kidney disease
B. medullary cystic kidney disease
C. autosomal recessive polycystic kidney disease
D. medullary sponge kidney
_____24. Patient was complaining of reducing urine output after he started taking
rifampicin and isoniazid for pulmonary tuberculosis. The lab test shows normal sgpt
but creatinine is 3.5mg/dl (baseline of 1.0mg/dl at start of treatment). Urinalysis shows
eosinophilia with WBC cast. What is the expected etiology of the renal failure?
A. Acute tubular necrosis
B. Acute Glomerulonephritis
C. Acute Interstitial nephritis
D. Acute Vascular thromobosis
APMC Board Exam Internal Medicine 2005 page 5
_____26. Which of the following physical findings suggest left ventricular heart
failure?
A. Pulsus paradoxus
B. Pulsus alternans
C. Bisferiens pulse
D. Pulsus tardus
_____27. Which of the following statement is true of right bundle bunch block?
A. Only occur in pathologic conditions, that is in coronary artery disease.
B. May occur in subjects without structural heart conditions
C. May occur in patients with atrial septal defect
D. B and C
_____29. In patients with severe knee osteoarthritis and chronic obstructive lung
disease, the best way to test for myocardial ischemia is to do:
A. Adenosine stress echo
B. Dipyridamole stress echo
C. Dobutamine stress echo
D. None of the above
_____33. In a patient with abdominal aortic aneurysm, what diameter of the aortic
aneurysm is surgery absolutely indicated?
A. 4 cm
B. 4.5 cm
C. 5 cm
D. 5.5 cm
_____34. In treating deep vein thrombosis, the following statements are true:
A. Anticoagulation should be continued for 1 to 3 months
B. INR should be maintained between 2.5 to 3.5
C. Low molecular weight heparin should be started first then overlapped with
warfarin
D. all of the above
_____ 36. In a patient presenting with upper respiratory tract infection, the sudden
onset of chest pain with pericardial friction rub and heart failure is usually due to:
A. Hepatitis B virus
B. Herpesviruses
C. Coxsackievirus
D. Measles virus
APMC Board Exam –Internal Medicine 2005 page 7
_____37. In patients with suspected dengue hemorrhagic fever, the following should
be done:
A. Infusion of crystalloid or colloid to prevent hemoconcentration
_____38. Which of the following viral agent does not cause hemorrhagic fever:
A. Dengue virus
B. Ebola virus
C. Hantavirus
D. HTLV I
_____43. Which of the following antibacterial agents does not penetrate cells well
A. Ampicillin
B. Macrolide
C. Metronidazole
D. Quinolones
_____46. Very distinctive, pruritic small wheals that are surrounded by large areas of
erythema sometimes precipitated by fever or hot baths, are seen in:
A. Cholinergic Urticaria
B. Light urticaria
C. Vibratory angioedema
D. Aquagenic pruritus
_____50. A transient, pruritic linear wheal with a flare at a site in which the skin is
briskly stroked with a firm object is known as:
A. Dermatosis
B. Dermographics
C. Dermatography
D. Dermographism
_____51. The following are included in the criteria for the classification of Systemic
Lupus Erythematosus except:
A. Butterfly rash
B. Alopecia
C. Photosensitivity
D. Serositis
_____63. Telomerase, a protein found at the distal ends of DNA strands, normally fall
off. However, if it does not fall off, one of the following occurs:
A. Production of Immortal cells
B. Diseases of aging
C. Point mutation
D. Spontaneous regression
_____66. Which of the following treatment may reverse the cytopenia in patients with
advanced Idiopathic myelofibrosis?
A. Hydroxyurea
B. Interferon
C. Splenectomy
D. Plateletpheresis
_____69. The differentiating agent that do not produce DIC and promotes
promyelocytic maturation in AML M3:
A. All-cis retinoic acid
B. All-trans retinoic acid
C. Tretinoin
D. Vitamin A
_____72. Which of the following drug used for treating peptic ulcer disease should be
avoided in patients with renal failure
A. Sucralfate
B. Famotidine
C. Aluminum Hydroxide-Magnesium Hydroxide antacid
D. A and C
_____74. The most common organism isolated from the ascitic fluid of patients with
spontaneous bacterial peritonitis is:
A. Streptococcus pneumoniae
B. Staphylococcus aureus
C. Escherichia Coli
D. Bacteroides Fragilis
APMC Board Internal Medicine 2005 page 13
_____77. A 71 y.o. woman with a history of coronary artery disease presents to her
family physician for a routine check up. The physician notices that she has lost 20 lbs
since her last visit 6 months ago. When questioned, she gives a history of intermittent
periumbilical pain that always begins about 30min. after eating and lasts for about 2
hours. She claims that the pain is more after a large meal so she began to eat less out of
fear of the pain. The most likely diagnosis is:
A. Pancreatitis
B. Cholecystitis
C. Small bowel obstruction
D. Intestinal Ischemia
_____78. A 48 y.o. man with a history of alcohol abuse presents to the emergency room
vomiting bright red blood. All of the following should be included in the differential
diagnosis except:
A. Ruptured Esophageal varices
B. Esophageal Reflux secondary to a hiatal hernia
C. Boerhaave’s syndrome
D. Mallory Weiss Syndrome
_____79. The most common site for ischemic colitis to occur is:
A. Splenic Flexure
B. Cecum
C. Rectum
D. Sigmoid Colon
_____80. All of the factors listed below may play a role in the development of duodenal
ulcer disease except:
A. Tobacco smoking
B. Helicobacter Pylori infection
C. Spicy Food ingestion
D. Genetic Factors
APMC Board Exam Internal Medicine 2005 – page 14
_____87. A 28 year old male with mild hypertension had controlled blood pressure, he
suddenly developed hypertensive crisis with an elevated 24 hr urine metanephrines,
what is the most likely cause of his condition
A. Renal Artery Stenosis
B. Cushings syndrome
C. Pheochromocytoma
D. none of the above
APMC Board Exam – Internal Medicine 2005 -page 15
_____88. The most reliable thyroid function test for diagnosing primary hypothyroidism:
A. Thyrotropin
B. Thyroid Stimulating Hormone
C. Free T4
D. Thyroid Scan
_____91. You suspect a patient to have acromegaly. To screen for this problem you
check:
A. IGF 1 level
B. Random Growth Hormone
C. TSH and T4 levels
D. serum ACTH level
_____92. A patient presents with polyuria and polydipsia. Serum sodium is 145 meq/l
with a dilute urine with specific gravity of 1.005. Patient has normal response to water
deprivation without any response to exogenous AVP (vasopressin). The condition is
consistent with:
A. Dipsogenic diabetes insipidus
B. Central diabetes insipidus
C. Nephrogenic diabetes insipidus
D. SIADH
_____93. A 45 y.o. male presents with infertility. On examination he was noted to have
small firm testes and gynecomastia. The following statements is true of the above
condition:
A. Most likely due to a secondary cause like pituitary gland trauma
B. Rule out possibility of exogenous estrogen intake
C. basic defect is a chromosomal abnormality= 47 XXY
D. Biochemical tests will reveal: low testosterone and low LH/FSH levels
APMC Board Exam – Internal Medicine 2005 page 16
_____95. 32 y.o. female with high blood sugar was examined to have “moon facies”,
truncal obesity with thin extremities, easy bruisibility and abdominal striae. She has an
excess of which hormone
A. ACTH
B. Growth Hormone
C. Cortisol
D. A and C
_____96. This syndrome is described as “an imposter has replaced your relative”:
A. Munchausen’s syndrome
B. Capgras syndrome
C. Delirium Tremens
D. Rogers Syndrome
_____97. The following drugs are used in the treatment of bipolar disorders:
A. Lithium carbonate
B. Valproic Acid
C. Carbamezepine
D. All of the above
Answer Key:
1. C Harrisons 16th edition, chapter 240 page 1542
2. D Harrisons 16th edition, chapter 239 page 1539
3. D Harrisons 16th Edition, chapter 238 page 1522-23
4. B Harrisons 16th edition, chapter 236 page 1513
5. B Harrisons 16th edition, chapter 235 page 1505
6. A Harrisons 16th edition, chapter 241 page 1545
7. D Harrisons 16th edition, chapter 244 page 1562
8. A Harrisons 16th edition, chapter 245 page 1567
9. D Harrisons 16th edition, chapter 246 page 1571
10. A Harrisons 16th edition, chapter 248 page 1577
11. D Harrisons 16th edition, chapter 372 page 2563
12. B Harrisons 16th edition, chapter 349 page 2375
13. B Harrisons 16th edition, chapter 349 page 2377
14. B Harrisons 16th edition, chapter 350 page 2394
15. B Harrisons 16th edition, chapter 350 page 2398-2399
16. C Harrisons 16th edition, chapter 264 page 1681
17. D Harrisons 16th edition, chapter 260 page 1645-1647
18. C Washington Manual of Medical Therapeutics 30th Chap. 3 page 58-59
19. C Harrisons 16th edition, chapter 264 page 1687
20. B Harrisons 16th edition, chapter 263 page 1673
21. B Washington Manual of Medical Therapeutics 30th Chap. 12 page 271
22. C Harrisons 16th edition, chapter 268 page 1712
23. C Harrisons 16th edition, chapter 265 page 1696
24. C Harrisons 16th edition, chapter 260 page 1648
25. D Harrisons 16th edition, chapter 263 page 1673
26. B Harrisons 16th edition, chapter 209 page 1305
27. D Harrisons 16th edition, chapter 210 page 1315
28. C Harrisons 16th edition, chapter 211 page 1325
29. C Harrisons 16th edition, chapter 211 page 1324
30. D Harrisons 16th edition, chapter 213 page 1336
31. D Harrisons 16th edition, chapter 213 page 1337
32. D Harrisons 16th edition, chapter 214 page 1350-1351
33. D Harrisons 16th edition, chapter 231 page 1483
34. C Harrisons 16th edition, chapter 232 page 1492
35. D Harrisons 16th edition, chapter 228 page 1453-1454
36. C Harrisons 16th edition, chapter 175 page 1145
37. A Harrisons 16th edition, chapter 180 page 1173
38. D Harrisons 16th edition, chapter 180 page 1170
39. A Harrisons 16th edition, chapter 187 page 1187
40. C Harrisons 16th edition, chapter 155 p988, chap 198 p1243 chap 202 p1260
41. D Harrisons 16th edition, chapter 132 p871, chap 160 p1011 chap 121 p824
42. D Harrisons 16th edition, chapter 120 page 821
43. A Harrisons 16th edition, chapter 118 page 790
44. D Harrisons 16th edition, chapter 150 page 963
45. A Harrisons 16th edition, chapter 107 page 720
46. A Harrisons 16th edition, chapter 298 page 1951
47. D Harrisons 16th edition, chapter 48 page 299
48. D Harrisons 16th edition, chapter 49 page 311
49. B Harrisons 16th edition, chapter 306 page 2007
50. D Harrisons 16th edition, chapter 298 page 1951
51. B Harrisons 16th edition, chapter 300 page 1962
52. D Harrisons 16th edition, chapter 303 pages 1979-1981
53. C Harrisons 16th edition, chapter 307 page 2014
54. D Harrisons 16th edition, chapter 306 page 2009-2010
55. D Harrisons 16th edition, chapter 300 page 1964
56. C Harrisons 16th edition, chapter 304 pages 1990-1991
57. A Harrisons 16th edition, chapter 369 page 2541
58. A Harrisons 16th edition, chapter 301 page 1972
59. A Harrisons 16th edition, chapter 300 pages 1962-1963
60. A Harrisons 16th edition, chapter 296 page 1937
61. B Harrisons 16th edition, chapter 70 pages 479-481
62. B Harrisons 16th edition, chapter 70 page 467
63. A Harrisons 16th edition, chapter 69 page 454
64. D Harrisons 16th edition, chapter 69 page 458-459
65. B Harrisons 16th edition, chapter 69 page 462-463
66. C Harrisons 16th edition, chapter 95 page 629
67. B Harrisons 16th edition, chapter 96 page 637
68. D Harrisons 16th edition, chapter 254 page 1611
69. C Harrisons 16th edition, chapter 96 page 636
70. A Harrisons 16th edition, chapter 98 page 658
71. B Harrisons 16th edition, chapter 289 page 1868
72. D Harrisons 16th edition, chapter 274 page 1753-1754
73. D Harrisons 16th edition, chapter 274 page 1761
74. C Harrisons 16th edition, chapter 112 page 750
75. B Harrisons 16th edition, chapter 294 page 1898
76. D Harrisons 16th edition, chapter 285 pages 1822-1825, 1834
77. D Harrisons 16th edition, chapter 279 page 1799
78. B Harrisons 16th edition, chapter 273 pages 1745-1746
79. A Harrisons 16th edition, chapter 279 pages 1797-1798
80. C Harrisons 16th edition, chapter 274 pages 1750-1753
81. D Harrisons 16th edition, chapter 297 page 1940, 1946-7
82. C Harrisons 16th edition, chapter 295 page 1922
83. D Harrisons 16th edition, chapter 295 page 1907, 1913-1915
84. A Harrisons 16th edition, chapter 298 page 1947-1949
85. D Harrisons 16th edition, chapter 298 page 1953
86. D Harrisons 16th edition, chapter 323 page 2161
87. D Harrisons 16th edition, chapter 322 page 2151
88. B Harrisons 16th edition, chapter 320 page 2111
89. B Harrisons 16th edition, chapter 321 page 2139
90. B Harrisons 16th edition, chapter 318 page 2086
91. A Harrisons 16th edition, chapter 318 page 2090
92. A Harrisons 16th edition, chapter 319 page 2098-2099
93. C Harrisons 16th edition, chapter 328 page 2215
94. B Harrisons 16th edition, chapter 318 page 2090
95. D Harrisons 16th edition, chapter 321 page 2134
96. B Harrisons 16th edition, chapter 350 page 2398
97. D Harrisons 16th edition, chapter 371 page 2556-2557
98. A Harrisons 16th edition, chapter 371 page 2559-2560
99. D Harrisons 16th edition, chapter 371 page 2549-2550
100. D Harrisons 16th edition, chapter 371 page 2553
MPL:
1. 65% 26. 80% 51. 85% 76. 60%
2. 70% 27. 60% 52, 65% 77. 40%
3. 80% 28. 65% 53. 75% 78. 65%
4. 90% 29. 60% 54. 75% 79. 70%
5. 75% 30. 60% 55. 90% 80. 75%
6. 90% 31. 50% 56. 65% 81. 40%
7. 70% 32. 50% 57. 60% 82. 50%
8. 75% 33. 50% 58. 60% 83. 60%
9. 70% 34. 55% 59. 85% 84. 50%
10. 80% 35. 75% 60. 85% 85. 40%
11. 80% 36. 70% 61. 80% 86. 55%
12. 90% 37. 95% 62. 70% 87. 60%
13. 85% 38. 85% 63. 60% 88. 75%
14. 80% 39. 90% 64. 40% 89. 70%
15. 60% 40. 65% 65. 40% 90. 65%
16. 85% 41. 60% 66. 50% 91. 65%
17. 75% 42. 100% 67. 65% 92. 50%
18. 95% 43. 80% 68. 90% 93. 75%
19. 60% 44. 65% 69. 60% 94. 65%
20. 70% 45. 85% 70. 65% 95. 80%
21. 65% 46. 70% 71. 75% 96. 65%
22. 75% 47. 70% 72. 45% 97. 80%
23. 75% 48. 65% 73. 70% 98. 60%
24. 65% 49. 70% 74. 85% 99. 65%
25. 60% 50. 70% 75. 60% 100. 65%
Blueprint:
A. Percentage by subject:
1. Pulmonary - 10%
2. Neurology - 5%
3. Nephrology - 10%
4. Cardiology - 10%
5. Infectious Diseases – 10%
6. Dermatology - 5%
7. Rheumatology – 10%
8. Oncology – 5%
9. Hematology – 5%
10. Gastroenterology – 10%
11. Allergy/Immunology – 5%
12. Endocrinology – 10%
13. Psychiatry – 5%
B. Types of Questions:
1. Recall - 52 %
2. Analysis - 42 %
3. Case/Problem Solving - 6 %